Equity

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Lyka Labs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500259 NSE Symbol: LYKALABS P/E (TTM) :0
ISIN Demat:INE933A01014 Div & Yield %:0 EPS (TTM) :0
Book Value (RS) :30.0720157 Market Cap (Rs Cr.):392.12 Face Value (RS) :10
    Change Company 
Particulars Quarter Ended
(Dec 2023)
Quarter Ended
(Dec 2022)
Quarter Ended
(% Var)
Sales 31.42 17.13 83.42
Other Income 0.52 1.11 -53.15
PBIDT 6.38 -3.56 0.00
Interest 1.26 3.04 -58.55
PBDT 5.12 -6.61 0.00
Depreciation 2.72 3.33 -18.32
PBT 2.40 -9.94 0.00
Tax 0.91 0.55 65.45
Deferred Tax 0.13 -0.27 0.00
PAT 1.36 -10.21 0.00

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)